CVS Health vs Labcorp
CVS Health is the larger business, with $402.07bn of revenue in fiscal 2025 against $13.95bn for Labcorp (28.8 times as much). CVS Health grew faster (7.8% against 7.2%). Labcorp kept more of each dollar of sales as profit: a net margin of 6.3% against 0.4%.
| Latest fiscal year | CVS HealthCVS, 2025 | LabcorpLH, 2025 |
|---|---|---|
| Revenue | $402.07bn | $13.95bn |
| Revenue growth | 7.8% | 7.2% |
| Net income | $1.77bn | $877m |
| Operating margin | — | 9.9% |
| Net margin | 0.4% | 6.3% |
| Return on equity | 2.3% | 10.5% |
| Free cash flow | $7.81bn | $1.21bn |
| Cash | $8.45bn | $532m |
| Total debt | $64.57bn | $5.58bn |
| Debt to equity | — | 64.8% |
| Dividend per share | $2.66 | $2.88 |
| Dividend yield | 3.0% | 0.8% |
| Share buybacks | $0 | $450m |
| Employees | 300,000 | — |
| Market value | $116.99bn | $28.61bn |
| Price vs our value range | Within our value range | Within our value range |
| Moat score | 39 (Weak) | 61 (Moderate) |
| Insider trades, 12 months | 0 buys, 8 sales | 0 buys, 20 sales |